On 21-January-2021 (Thursday), 11.08% shares of BIOLASE, Inc. (NASDAQ:BIOL) are owned by insiders with 0.00% six-month change in the insider ownership. The insider filler data counts the number of monthly positions over 3 month and 12 month time spans. For BIOLASE, Inc. (NASDAQ:BIOL) total 0 number of trades held during last 3 months and 3 during last 12 months, out of them 0 numbers of buys held in last 3 months and 0 buys in last 12 months. Whereas 0 numbers of sells held in last 3 months and 3 sells over the past 12 months.
For the duration of last three months BIOLASE, Inc. (NASDAQ:BIOL)’s total number of shares bought are 0 and sold 0 from a total of 0 traded shares. During last twelve months 0 number of shares bought and 6,481,181sold from a total of 6,481,181shares traded. A net activity of 0 took place in the course of three months, while 6,481,181during last twelve months. Insider trading information is derived from Forms 3 and 4 filings are filed with the U.S. Securities and Exchange Commission (SEC).
BIOL shares had a relatively better volume day versus average trading capacity of 58,519,749 shares, but with an 23.87M float and a 236.98% run over a month, it’s definitely worthy for investors
BIOLASE, Inc. (NASDAQ:BIOL) belongs to Healthcare sector and Medical Devices industry. The company’s Market capitalization is $98.85M with the total Outstanding Shares of 93.51M. BIOL‘s stock construct a change of 14.73% in a total of its share price and finished its trading at 1.11.
After a stumble in the market that brought BIOL to its low price for the period of the last 52 weeks, BIOLASE, Inc. was unable to take a rebound, for now settling with 423.70% of loss for the given period.
BIOLASE, Inc. (NASDAQ:BIOL): Having a glance at past record, we’re going to look at various forwards or backwards shifting developments regarding BIOL. The firm’s shares fell -7.39% in the past five business days. In the previous quarter, the stock rose 217.75% at some point. The output of the stock increased 114.02% within the six-month closing period, while general annual output gained 10.70%. The company’s performance is now positive at 131.13% from the beginning of the calendar year.
Earnings per Share Details of BIOLASE, Inc.
Let’s take a quick analysis at BIOL’s past reported and future predictions of growth using the EPS Growth. EPS growth is a percentage change in standardized earnings per share over the trailing-twelve-month period to the current year-end.
The company posted a value of $28.40% as earning-per-share over the last full year, while a chance, will post $75.00% for the coming year. In-depth, if we analyze for the long-term EPS Growth, the out-come was 19.20% for the past five years and the scenario is totally different as the prediction was 20.00% for the next five year.
P/S, P/E, P/C and P/B/ SMA50, SMA 200 of BIOL is described below
The price-to-sales is a valuation ratio that relates a company’s stock price to its revenues. The price-to-sales ratio is a symbol of the value placed on each dollar of a company’s sales or taxes. As of now, BIOL has a P/S, P/E and P/B values of 4.05, 0 and 5.67 respectively. P/E and P/B ratios both are used on a regular basis by the investor to measure the value of the company and to get the right amount of the share.
Its P/Cash valued at 5.26. The price-to-cash-flow ratio is a stock valuation indicator that measures the value of a stock’s price to its cash flow per share. Investors focus on the profitability proportions of the company that how the company performs at profitability side. Return on equity ratio or ROE is a significant indicator for prospective investors as they would like to see just how effectively a business is using their cash to produce net earnings.
Volatility Insights of BIOL
Watching some historical volatility numbers on shares of BIOLASE, Inc. (BIOL) we can see that the 30 days volatility is presently 21.22%. The 7 days volatility is 25.09%. Following volatility data can help measure how much the stock price has fluctuated over the specified time period.
The company has a beta of BIOLASE, Inc. 1.00 indicates that its price is correlated with the market. Less than 1.00 shows less volatility than the market. Beta greater than 1.00 indicates that the security’s price is theoretically more volatile than the market.
“BIOL” (Technical Considerations)
As a return on equity, BIOLASE, Inc. (NASDAQ: BIOL) produces 0. Because it would be easy and highly flexible, ROI measurement is among the most popular investment ratios. Executives could use it to evaluate the levels of performance on acquisitions of capital equipment whereas investors can determine that how the stock investment is better.
The ROI entry for BIOL’s scenario is at -112.90%. Another main metric of a profitability ratio is the return on assets ratio or ROA that analyses how effectively a business can handle its assets to generate earnings over duration of time. BIOLASE, Inc. (BIOL) generated -108.10% ROA for the trading twelve-month.
What do you mean by simple moving average (SMA)?
Based on a recent bid, its distance from 20 days simple moving average is 86.07%, and it has a distance of 175.61% from the 200 days simple moving average.
The payout ratio shows the proportion of earnings paid out as dividends to shareholders, typically expressed as a percentage of the company’s earnings. It can also be expressed as dividends paid out as a proportion of cash flow. This is also known as the dividend payout ratio. BIOL’s payout ratio was 0 and Price to free cash flow remained $0.
Its quick ratio for most recent quarter was 1.10 along with current ratio for most recent quarter of 1.70. Total debt to equity ratio of the company for most recent quarter was 1.17 whereas long term debt to equity ratio for most recent quarter is 0.23.